Artikel
High-grade intracranial gliomas exhibit wide-spread impaired cerebrovascular reactivity
Suche in Medline nach
Autoren
Veröffentlicht: | 8. Juni 2016 |
---|
Gliederung
Text
Objective: In pre-surgical planning of intracranial high-grade gliomas, false negative task based fMRI activation, termed neurovascular uncoupling, can potentially lead to the undesirable resection of eloquent areas. Neurovascular uncoupling may be identified with BOLD derived cerebrovascular reactivity (CVR), where impaired CVR results in decreased fMRI task-based activation in eloquent areas. Till now, CVR has not been spatially quantified for high-grade intracranial gliomas.
Method: Twelve subjects (mean age 55 ± 18) with high-grade gliomas (WHO grade III or IV) underwent a preoperative standardized hypercapnic challenge during 3T BOLD MRI acquisitions. The tumor was masked using an automated subtraction analysis based on (non)contrast enhanced T1-weighted and FLAIR T2 volumes. Voxels with FLAIR hyperintensities and a positive subtraction value were determined to be the tumor outline. Around the tumor, CVR was determined in 7 concentric rings with an individual expansion of 3mm. As comparison a mirror contralateral analysis was done. Furthermore, 10 healthy controls were included.
Results: Whole brain CVR of high-grade glioma subjects was significantly impaired compared to healthy controls (0.11 ± 0.10 versus 0.28 ± 0.8, p<0.01) Intratumoral CVR was 0.04 ± 0.07. Perifocal CVR exhibited an increasing CVR with every consecutive concentric ring expansion up to 12mm perifocally. However, this remained significantly impaired as to CVR measured in controls. No such trend was observed in the contralateral hemisphere.
Conclusions: Whole brain CVR of subjects with high-grade gliomas is impaired, with a more severe CVR impairment seen in tumor tissue and the first 12mm perifocally. No such trend was found on the contralateral side. BOLD-derived quantitative CVR measurements may provide a potential tool to assess neurovascular uncoupling in high-grade glioma.